COMPOUNDS DERIVED FROM QUINONES AND THEIR USE AGAINST LEISHMANIA spp.

Patent number:

P202030581

Islas Canarias.svg
No items found.

The present invention relates to compounds derived from quinones with leishmanicidal activity and their use thereof in the pharmaceutical sector, specifically in the field of parasitic diseases. Specifically, it relates to compounds of formula I, their isomeric forms and salts thereof.

Countries:
Spain
Regions:
Canary Islands
Centers:
UNIVERSIDAD DE LA LAGUNA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

Application for use in the treatment of leishmaniasis. - High efficacy - Low toxicity. - Significant improvement over reference treatment with Miltefosine. - Synthetic procedure from readily available and low cost commercial compounds instead of extraction from natural source.

Comments

Other related patents

Health

ELECTROCHEMICAL SENSOR SYSTEMS FOR SENSING ANALYTICAL REACTIONS AND BIOLOGICAL OPERATIONS AND METHODS

Countries
Spain
Know more
Health

METHOD FOR SCREENING AND/OR EVALUATING THE EFFICACY OF MEDICAMENTS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES AND MELAS SYNDROME

Countries
Spain
Know more
Health

COMPOUNDS THAT SELECTIVELY AND EFFECTIVELY INHIBIT HAKAI-MEDIATED UBIQUITINATION, AS ANTI-CANCER DRUGS

Countries
Spain
Know more
Get back to patents directory